| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157434 | American Journal of Kidney Diseases | 2014 | 8 Pages |
Abstract
Reductions in baseline eGFR decrease the survival benefit associated with the ICD. These findings should be confirmed by additional studies specifically targeting patients with varying eGFRs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Patrick H. MD, MHS, Sana M. MD, MHS, Joo Yoon BS, Rex BA, Gust H. MD, J. Thomas MD, Alfred E. MD, Arthur J. MD, Kerry L. PhD, Richard AB, Paul MD, Al PhD, Riccardo MD, Alan H. MD, Peter J. MD, Daniel B. MD, MPH, Paul L. MD, Lurdes Y.T. PhD,